The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACCURAY INC | COM | 004397105 | 1,868 | 674,300 | SH | SOLE | 674,300 | 0 | 0 | ||
ACHILLION PHARMACEUTICALS | COM | 00448Q201 | 1,580 | 438,884 | SH | SOLE | 438,884 | 0 | 0 | ||
ADVAXIS INC | COM NEW | 007624307 | 93 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 5,531 | 287,748 | SH | SOLE | 287,748 | 0 | 0 | ||
AILERON THERAPEUTICS INC | COM | 00887A105 | 67 | 99,502 | SH | SOLE | 99,502 | 0 | 0 | ||
AKEBIA THERAPEUTICS INC | COM | 00972D105 | 3,246 | 828,038 | SH | SOLE | 828,038 | 0 | 0 | ||
ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 11,995 | 636,013 | SH | SOLE | 636,013 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 264 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ALECTOR INC | COM | 014442107 | 2,091 | 145,000 | SH | SOLE | 145,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 4,090 | 169,800 | SH | SOLE | 169,800 | 0 | 0 | ||
APPLIED GENETIC TECHNOL CORP | COM | 03820J100 | 1,494 | 359,190 | SH | SOLE | 359,190 | 0 | 0 | ||
ARCTURUS THERAPEUTICS HLDG I | COM | 03969T109 | 1,786 | 173,914 | SH | SOLE | 173,914 | 0 | 0 | ||
ARDELYX INC | COM | 039697107 | 2,728 | 580,524 | SH | SOLE | 580,524 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 4,300 | 93,942 | SH | SOLE | 93,942 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 2,504 | 21,969 | SH | SOLE | 21,969 | 0 | 0 | ||
ARQULE INC | COM | 04269E107 | 3,802 | 530,262 | SH | SOLE | 530,262 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 5,825 | 60,480 | SH | SOLE | 60,480 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 497 | 50,573 | SH | SOLE | 50,573 | 0 | 0 | ||
ATRICURE INC | COM | 04963C209 | 7,949 | 318,729 | SH | SOLE | 318,729 | 0 | 0 | ||
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 1,242 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
BELLICUM PHARMACEUTICALS INC | COM | 079481107 | 210 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 1,385 | 483,388 | SH | SOLE | 483,388 | 0 | 0 | ||
BIOHAVEN PHARMACEUTICALS HOLD | COM | G11196105 | 3,963 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
BIOTELEMETRY INC | COM | 090672106 | 1,845 | 45,300 | SH | SOLE | 45,300 | 0 | 0 | ||
BIOXCEL THERAPEUTICS INC | COM | 09075P105 | 898 | 127,500 | SH | SOLE | 127,500 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 2,341 | 25,500 | SH | SOLE | 25,500 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 9,053 | 123,218 | SH | SOLE | 123,218 | 0 | 0 | ||
CARA THERAPEUTICS INC | COM | 140755109 | 6,927 | 378,924 | SH | SOLE | 378,924 | 0 | 0 | ||
CARDIOVASCULAR SYSTEMS INC | COM | 141619106 | 2,195 | 46,200 | SH | SOLE | 46,200 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COM | 171757107 | 199 | 99,993 | SH | SOLE | 99,993 | 0 | 0 | ||
CORBUS PHARMACEUTICALS HLDGS | COM | 21833P103 | 1,448 | 297,300 | SH | SOLE | 297,300 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 1,792 | 349,996 | SH | SOLE | 349,996 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 4,765 | 418,727 | SH | SOLE | 418,727 | 0 | 0 | ||
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 738 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
DERMIRA INC | COM | 24983L104 | 665 | 104,000 | SH | SOLE | 104,000 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 5,423 | 36,338 | SH | SOLE | 36,338 | 0 | 0 | ||
DEXCOM INC | NOTE 0.750% 5/1 | 252131AF4 | 397 | 250,000 | PRN | SOLE | 250,000 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 1,699 | 118,314 | SH | SOLE | 118,314 | 0 | 0 | ||
ELOXX PHARMACEUTICALS INC | COM | 29014R103 | 1,695 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 1,258 | 121,986 | SH | SOLE | 121,986 | 0 | 0 | ||
EVELO BIOSCIENCES INC | COM | 299734103 | 122 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 7,299 | 470,000 | SH | SOLE | 470,000 | 0 | 0 | ||
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 929 | 305,500 | SH | SOLE | 305,500 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 8,016 | 52,509 | SH | SOLE | 52,509 | 0 | 0 | ||
GAMIDA CELL LTD | SHS | M47364100 | 1,182 | 272,909 | SH | SOLE | 272,909 | 0 | 0 | ||
GENOCEA BIOSCIENCES INC | COM NEW | 372427401 | 1,573 | 542,564 | SH | SOLE | 542,564 | 0 | 0 | ||
GRITSTONE ONCOLOGY INC | COM | 39868T105 | 432 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
INOGEN INC | COM | 45780L104 | 1,102 | 23,000 | SH | SOLE | 23,000 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 529 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
ISHARES TR NASDAQ BIOTECH | ETF | 464287556 | 6,458 | 64,900 | SH | SOLE | 64,900 | 0 | 0 | ||
JOHNSON AND JOHNSON | COM | 478160104 | 1,216 | 9,400 | SH | SOLE | 9,400 | 0 | 0 | ||
KADMON HOLDINGS INC | COM | 48283N106 | 2,233 | 886,177 | SH | SOLE | 886,177 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 287 | 24,725 | SH | SOLE | 24,725 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 183 | 11,192 | SH | SOLE | 11,192 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 1,572 | 103,658 | SH | SOLE | 103,658 | 0 | 0 | ||
LINEAGE CELL THERAPEUTICS IN | COM | 53566P109 | 93 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
LUMINEX CORP | COM | 55027E102 | 4,214 | 204,091 | SH | SOLE | 204,091 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 2,552 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 569 | 6,600 | SH | SOLE | 6,600 | 0 | 0 | ||
MASIMO CORPORATION | COM | 574795100 | 446 | 3,000 | SH | SOLE | 3,000 | 0 | 0 | ||
MENLO THERAPEUTICS INC | COM | 586858102 | 3,839 | 856,936 | SH | SOLE | 856,936 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 793 | 501,736 | SH | SOLE | 501,736 | 0 | 0 | ||
NATUS MEDICAL INC | COM | 639050103 | 1,366 | 42,900 | SH | SOLE | 42,900 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 5,813 | 64,508 | SH | SOLE | 64,508 | 0 | 0 | ||
NEURONETICS INC | COM | 64131A105 | 883 | 106,247 | SH | SOLE | 106,247 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 1,823 | 21,210 | SH | SOLE | 21,210 | 0 | 0 | ||
OBSEVA SA | COM | H5861P103 | 535 | 64,231 | SH | SOLE | 64,231 | 0 | 0 | ||
ORAMED PHARMACEUTICALS INC | COM NEW | 68403P203 | 51 | 16,000 | SH | SOLE | 16,000 | 0 | 0 | ||
PHASEBIO PHARMACEUTICALS INC | COM | 717224109 | 1,503 | 360,542 | SH | SOLE | 360,542 | 0 | 0 | ||
PREVAIL THERAPEUTICS INC | COM | 74140Y101 | 921 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
PROQR THERAPEUTICS N V | SHS EURO | N71542109 | 1,506 | 261,521 | SH | SOLE | 261,521 | 0 | 0 | ||
RADIUS HEALTH INC | COM NEW | 750469207 | 567 | 22,000 | SH | SOLE | 22,000 | 0 | 0 | ||
RADIUS HEALTH INC | NOTE 3.000% 9/0 | 750469AA6 | 3,665 | 4,000,000 | PRN | SOLE | 4,000,000 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 295 | 157,700 | SH | SOLE | 157,700 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 17,509 | 124,806 | SH | SOLE | 124,806 | 0 | 0 | ||
SCYNEXIS INC | COM | 811292101 | 1,356 | 1,272,927 | SH | SOLE | 1,272,927 | 0 | 0 | ||
SPERO THERAPEUTICS INC | COM | 84833T103 | 418 | 39,395 | SH | SOLE | 39,395 | 0 | 0 | ||
STEREOTAXIS INC | COM NEW | 85916J409 | 48,019 | 13,680,554 | SH | SOLE | 13,680,554 | 0 | 0 | ||
SUNESIS PHARMACEUTICALS INC | COM | 867328700 | 663 | 920,995 | SH | SOLE | 920,995 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | 364 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
SYNLOGIC INC | COM | 87166L100 | 991 | 432,830 | SH | SOLE | 432,830 | 0 | 0 | ||
TRANSLATE BIO INC | COM | 89374L104 | 3,610 | 364,229 | SH | SOLE | 364,229 | 0 | 0 | ||
TURNING POINT THERAPEUTICS I | COM | 90041T108 | 1,779 | 47,308 | SH | SOLE | 47,308 | 0 | 0 | ||
UROGEN PHARMA LTD | COM | M96088105 | 357 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 1,439 | 209,200 | SH | SOLE | 209,200 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 4,056 | 197,554 | SH | SOLE | 197,554 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 2,979 | 330,667 | SH | SOLE | 330,667 | 0 | 0 | ||
ZAFGEN INC | COM | 98885E103 | 226 | 305,500 | SH | SOLE | 305,500 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 5,716 | 142,764 | SH | SOLE | 142,764 | 0 | 0 |